Bovine-derived sera remain the gold standard in cell culture supplements despite its many flaws, says Cook Regentec.
Cell therapy development and production will not be sustainable unless there is a vendor-led shift to automated processes, said experts in Brussels yesterday.
Regenerative medicine developers now have a new supplier for mesenchymal stem cells, the multipotent stromal cells derived from marrow and other tissues like muscle and dental pulp for tissue repair.
Quanterix claims the updated version of its Simoa immunoassay platform allows biopharma researchers to study diseases in more detail than ever before.
Approving a biosimilar for the same diseases as the originator drug based on extrapolated data rather than study results should remain a cornerstone of the review process say regulators and developers.